Evaluating Stairway Designs for Individuals With Vision Impairment
The University of Alabama in Huntsville · NCT07337317
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 65+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 65
- US sites recruiting
- 1
- Study start
- January 22, 2026
- Record last updated
- May 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to learn if contrast frequency on step tread-edges influences foot clearance measures, a marker of fall risk, in older adults with and without visual impairments.
The main questions that aim to be answered are how foot clearance measures change across different frequencies of stair contrast, and how experiences and perceptions of different stair contrast frequencies are evaluated.
Researchers will compare individuals with and without visual impairments to see if contrast frequency on step tread-edges changes.
Participants will attend one visit during which their vision will be measured, and they will be asked to ascend and descend laboratory stairs at different contrast frequencies.
An optional second visit will entail a focus group meeting to better understand how contrast affects mobility in their home and everyday life.
Being studied: Frequency of contrast marking on stair steps
Conditions: Vision, Low; Mobility Limitation
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- ≥ Contrast sensitivity log 1.6 or greater
- travels independently in the community, including stairways > two times/week
- comfortable ascending and descending a stairway with rest time provided
Exclusion Criteria
- severe rheumatologic and or orthopedic diseases (e.g., awaiting joint replacement, active inflammatory disease)
- lower-limb injuries and/or recent joint replacements (e.g., hip fracture, hip, or knee replacement within six months of study enrollment)
Recruiting US locations
University of Alabama in Huntsville
Huntsville, AL 35899
Site contact: Sara A Harper, PhD · 2568242184 · sah0075@uah.edu
Study contacts (from the official record)
- Sara A Harper, PhD · 2568242184 · sah0075@uah.edu
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65